TNI medical cleared to enter the US market

2018-11-21T15:35:24+00:0019. November 2018|

The U.S. Food and Drug Administration (FDA) has granted the company clearance for the use of TNI softFlow 50 to treat all adult patients who would benefit from receiving high flow warmed and humidified respiratory gases. The clearance covers use of the devices during inpatient treatment. The devices can be put into operation in US hospitals effective immediately.

Download Press Release